O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone
Authors:
- Renee BaileyRBRenee Bailey
- Mark KrisMKMark Kris
- Michael WolfMWMichael Wolf
- Andrea KayAKAndrea Kay
- Steven AverbuchSASteven Averbuch
- Jon AskaaJAJon Askaa
- Mette JanasMJMette Janas
- Karsten SchmidtKSKarsten Schmidt
- Masahiro FukuokaMFMasahiro Fukuoka
- 1 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S71